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Abstract
Background: Falls are a major cause of morbidity and mortality in dementia, but there have been no prospective studies of
risk factors for falling specific to this patient population, and no successful falls intervention/prevention trials. This
prospective study aimed to identify modifiable risk factors for falling in older people with mild to moderate dementia.
Methods and Findings: 179 participants aged over 65 years were recruited from outpatient clinics in the UK (38 Alzheimer’s
disease (AD), 32 Vascular dementia (VAD), 30 Dementia with Lewy bodies (DLB), 40 Parkinson’s disease with dementia (PDD),
39 healthy controls). A multifactorial assessment of baseline risk factors was performed and fall diaries were completed
prospectively for 12 months. Dementia participants experienced nearly 8 times more incident falls (9118/1000 person-years)
than controls (1023/1000 person-years; incidence density ratio: 7.58, 3.11–18.5). In dementia, significant univariate
predictors of sustaining at least one fall included diagnosis of Lewy body disorder (proportional hazard ratio (HR) adjusted
for age and sex: 3.33, 2.11–5.26), and history of falls in the preceding 12 months (HR: 2.52, 1.52–4.17). In multivariate
analyses, significant potentially modifiable predictors were symptomatic orthostatic hypotension (HR: 2.13, 1.19–3.80),
autonomic symptom score (HR per point 0–36: 1.055, 1.012–1.099), and Cornell depression score (HR per point 0–40: 1.053,
1.01–1.099). Higher levels of physical activity were protective (HR per point 0–9: 0.827, 0.716–0.956).
Conclusions: The management of symptomatic orthostatic hypotension, autonomic symptoms and depression, and the
encouragement of physical activity may provide the core elements for the most fruitful strategy to reduce falls in people
with dementia. Randomised controlled trials to assess such a strategy are a priority.
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Introduction
The prevalence of neurodegenerative disorders is increasing due
to changes in population demographics. It is estimated that by
2020 there will be 42 million people with a diagnosis of dementia
worldwide,[1] in whom the most common causes of dementia will
be Alzheimer’s disease (AD), Vascular dementia (VAD) and the
Lewy body dementias.[2,3] Falls are a significant cause of injuries,
loss of confidence, increased morbidity, institutionalisation and
mortality in all older people,[4,5] but particularly those with
dementia.[6,7] People with dementia recover less well after a fall
than those without dementia.[8] In view of the suffering caused by
such falls, and the enormous cost of caring for people with
dementia who have fallen, there is an urgent need to optimise the
prevention of falls in this group.
Importantly, there have been no prospective studies of
multifactorial risk factors for falling specific to the population
with dementia. Previous studies have identified multiple risk
factors for falls in the older population as a whole, in a variety of
settings. In multivariate studies significant risk factors include fall
history, gait, balance and mobility impairments, visual impair-
ment, cognitive impairment, fear of falling, environmental
hazards, muscle weakness and incontinence.[9] In community
settings, impairment on various cognitive measures has been
shown to be a risk factor for falls, although dementia itself has only
been examined and shown to be a risk factor for falls in
community dwelling people with Parkinson’s disease,[10] and in
residents of extended care settings.[7,11] The identification of
potentially modifiable risk factors has been critical in the
development of effective multifactorial falls intervention pro-
grammes, particularly for older people at high risk of falling.[12] It
is likely that falls in dementia are also multi-factorial in origin,
possibly with risk factors similar to those identified in the general
older population, but there may be other potentially modifiable
factors specific to dementia. It is thought that those with Lewy
body (LB) dementias are at particular risk, and a history of
recurrent falls is accepted as a supporting feature for the diagnosis
of dementia with Lewy bodies (DLB).[13]
Only one previous multifactorial intervention study has
exclusively recruited participants with dementia.[14] Interventions
were based upon those used in successful trials in people without
dementia, and the study did not show a significant reduction in
falls or number of fallers. However, 70% of the participants in this
trial lived in institutional settings, most had moderate to severe
PLoS ONE | www.plosone.org 1 May 2009 | Volume 4 | Issue 5 | e5521
cognitive impairment and all had already presented to hospital
with a fall. A recent systematic review of interventions to prevent
falls in hospitals and care homes suggested that effect size was
smaller in trials where the prevalence of dementia was high, but
meta-regressions were limited by incomplete reporting of dementia
prevalence.[15] It remains possible that multifactorial interven-
tions would be successful in patients with less severe dementia, but
we suggest that interventions in future trials should be tailored to
potentially modifiable factors which can be shown to predict falls
in community dwelling people with mild-moderate dementia.
There is therefore an urgent need to understand risk factors for
falls in dementia to enable a more tailored and effective
intervention to be developed.
Participants in this study completed a multifactorial baseline
assessment of putative predictors of falls and then completed
prospective falls diaries for a period of 12 months, which is known
to be a robust method of ascertainment of falls. We aimed to
identify potentially modifiable predictors of falls in older people
with mild-moderate dementia, the majority of whom lived in the
community.
Methods
Ethics statement
This study was approved by the Joint Ethics Committee of
Newcastle and North Tyneside Health Authority, the University of
Newcastle upon Tyne and the University of Northumbria at
Newcastle and participants gave written informed consent in
accordance with the declaration of Helsinki.
Design
Longitudinal cohort study.
Participant recruitment
We recruited consecutive cases with dementia (AD, VAD, DLB
or Parkinson’s disease dementia (PDD)) from Neurology, Old Age
Psychiatry and Geriatric Medical secondary care outpatient clinics
within the Northern Region of the United Kingdom. Cases were
referred to these clinics for assessment, diagnosis and management
by their primary care physician, or in the case of those with VAD
following a stroke, they may have been referred to a Psychiatrist by
their stroke physician. We recruited a healthy control group of
comparable age by local advertisement.
Inclusion and exclusion criteria
All participants were over 65 years of age. All diagnoses of
dementia were made according to DSM IV criteria. Significant
medical causes of dementia were excluded during diagnostic
investigations. Diagnoses were made by operationalised criteria for
AD,[16] VAD,[17] DLB[18] and PDD,[19] which have been
validated against neuropathological diagnosis within our
group.[20,21]
Participants were excluded if they declined participation, died
or withdrew from the study before commencing falls diaries, were
unable to perform the gait assessments due to other co-morbid
conditions, had an MMSE score[22] less than or equal to 8, or
were too visually impaired to complete cognitive assessments.
Controls were excluded if they had any evidence of dementia or
Parkinson’s disease.
Baseline Clinical Assessment
All participants received a detailed baseline assessment to
quantify putative risk factors for falls. The factors included were
selected on the basis of their previous identification as risk factors
in more than one high quality study in older people, and/or their
relevance to clinical features of dementia postulated to be
causative of falls in dementia.
Assessments included medical history (duration of dementia,
residence, history of previous falls and medications). Objective
assessments included the cognitive subsection of the CAMDEX
(CAMCOG),[23] a physical activity scale previously validated in
older people,[24] body mass index, performance-oriented assess-
ment of mobility[25] and the motor subsection of the Unified
Parkinson’s disease rating scale (UPDRS[26]) to evaluate extra-
pyramidal signs. Participants were assessed after taking their usual
dose of levodopa, if applicable, and were allowed to use their usual
walking aids.
Dementia specific scales were used to assess activities of daily
living (Bristol scale[27]), depression (Cornell scale[28,29]) and
behavioural and psychological symptoms of dementia (Neuropsy-
chiatric Inventory[30]), in addition to detailed autonomic
assessments as described below. These factors have all been
postulated as potential causes of falls in dementia, particularly in
the LB dementias.[13]
Autonomic Assessment
All assessments took place in the morning; participants refrained
from consuming caffeinated drinks or smoking on the morning of
the assessment. Assessments were carried out according to the
protocols described in our previous study.[31] Briefly, blood
pressure was monitored using a digital photoplethysmograph
(Portapres, TNO, Amsterdam), which enables non-invasive beat-
to-beat blood pressure measurement. Orthostatic hypotension
(OH) was defined as a fall in systolic blood pressure of greater than
20 mm Hg or diastolic blood pressure of greater than 10 mm Hg
that did not return to baseline within 30 seconds from the start of
the active stand. Return to baseline was defined as the start of a
series of 3 consecutive beats in which the blood pressure was
within one standard deviation of the baseline blood pressure.
Participants were asked to report symptoms on standing; if
dizziness, lightheadedness, unsteadiness or presyncope were
reported in the presence of OH this was defined as symptomatic
OH. Other clinical autonomic function tests included isometric
exercise, Valsalva manoeuvre and deep breathing. Ewing’s battery
was used to identify the presence of a clinical autonomic
neuropathy for each patient who had complied with sufficient
tests for the classification scheme to be applied.[32]
Outcome Measures
The primary outcome measures were prevalence and incidence
of falls occurring during the 12 month follow up period.
Secondary outcome measures were proportional hazard ratios
for time to first fall in dementia, according to diagnosis and status
of putative clinical predictors. A fall was defined as an event
whereby a person comes to lie on the ground or another lower
level with or without loss of consciousness. Participants were given
diaries to record the occurrence of falls, to be returned every four
weeks in a postage paid envelope. If the participants did not return
the diaries they were reminded by telephone after 2 weeks. The
caregiver was asked to assist in the completion of diaries when
dementia was present.
Statistics
Differences in baseline characteristics across groups were
compared using Fisher’s Exact test for categorical data, ANOVA
for normally distributed data and Kruskal-Wallis for non-normally
distributed data. Differences between individual groups were
compared using the Chi squared test for categorical data,
Falls in Dementia
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Student’s t test for normally distributed data and Mann-Whitney
U test for non-normally distributed data.
Due to censoring of falls data from some participants (as a result of
death or withdrawal from the study), Cox regression (adjusted for age
and sex) was used to obtain a proportional hazard ratio for time to
first fall in dementia, using healthy controls as the reference group.
The incidence density of falls in each diagnostic group was
calculated by the total number of falls in each group per number of
person years of diaries returned, expressed as number of falls per
1000 person years. Loglinear Poisson regression models (adjusted
for age and sex) were used to obtain an incidence density ratio for
dementia and its subtypes in comparison with healthy controls.
AD, VAD and DLB were also used as reference groups to examine
the effect of dementia subtype upon incidence of falls.
In order to examine the associations between exposure to putative
risk factors for falling and the occurrence of falls in those participants
with dementia, Cox regression was used to obtain univariate
proportional hazard ratios for each risk factor, adjusted for age and
sex, using time to the occurrence of at least one fall as the dependent
variable. Hazard ratios were given according to presence or absence
of the risk factor, or per point on quantitative scales as appropriate.
Analyses were performed initially for all participants with dementia,
and then repeated stratified by diagnosis.
Following identification in univariate models, significant and
potentially modifiable risk factors were entered into a multivariate
forward stepwise Cox regression model, p 0.05 for entry, p 0.1 for
removal. Age and sex were included even if not significant. Where
similar clinical features were described by more than one significant
risk factor the factor with the higher level of significance in
univariate analyses was entered into multivariate analyses, in order
to avoid co-aggregation of predictors; e.g. abnormal pull test rather
than the full Tinetti balance scale as both these tests assess balance.
Results
Participants
289 patients were considered for inclusion; 65 participants were
excluded (Figure 1). 179 (80%) of 224 eligible participants agreed
to take part (39 controls, 38 AD, 32 VAD, 30 DLB and 40 PDD).
116 (83%) of 140 participants with dementia and all of the controls
were residing in the community. A summary of baseline
characteristics of the participants is shown in table 1.
Prevalence of falls
81.6% of diaries were returned (82.9% in those participants
with dementia). During the 12 month follow up period 65.7% of
participants with dementia had at least one fall, compared with
35.9% of controls (relative hazard ratio (HR) adjusted for age and
sex: 3.03, 95% confidence intervals (CI) 1.71–5.35). With respect
to dementia subtypes, the prevalence of falls in AD was 47%; VAD
47%; DLB 77% and PDD 90%. Figure 2 shows the survival curves
until the occurrence of a fall for each diagnosis.
Incidence of falls
The incidence of falls in dementia was 9118 per 1000 person years,
which was significantly higher than in controls (1023; incidence
density ratio (IDR) adjusted for age and sex: 7.58, 95% CI: 3.11–
18.5), (table 2). If participants living in care homes were excluded, the
incidence of falls in dementia was 8763 which remained significantly
higher than in controls (IDR: 9.56, 95% CI: 6.07–15.1).
With respect to dementia subtypes, the incidence of falls,
adjusted for age and sex, was higher in all dementia subtypes than
in controls (table 2): AD: 2486 falls/1000 person years (IDR: 1.95;
95% CI: 1.01–3.78), VAD: 3135 (IDR: 1.77, 95% CI: 1.17–2.69),
DLB: 9087 (IDR: 6.06, 95% CI: 3.53–10.4) and PDD: 19000
(IDR: 20.5, 95% CI: 10.4–40.2). The incidence of falls in PDD
was higher than in AD (IDR: 10.5, 95% CI: 3.32–33.1), VAD
(IDR: 11.6, 95% CI: 5.73–23.3), and DLB (IDR: 3.38, 95% CI:
2.66–4.31). The incidence of falls in DLB was also higher in AD
(IDR: 3.10, 95% CI: 1.16–8.28) and VAD (IDR: 3.41, 95% CI:
1.96–5.95). The incidence of falls in VAD was not significantly
higher than in AD (IDR: 0.907, 95% CI: 0.504–1.63).
Univariate predictors of falls in dementia
Significant modifiable and non-modifiable predictors of falls in all
participants with dementia are shown in table 3. Significant predic-
Figure 1. Flow chart to show recruitment of patients to study.
doi:10.1371/journal.pone.0005521.g001
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tors included diagnosis of Lewy body disorder, history of falls or
recurrent falls in the preceding 12 months, use of cardioactive
medication, abnormal gait or balance score, Cornell depression score
$10, autonomic symptom scale.7, autonomic neuropathy, sympto-
matic OH and time taken for blood pressure to return to baseline on
standing. Age and increased physical activity were protective.
However, when univariate analyses were stratified by diagnosis,
only duration of dementia, history of falls or recurrent falls in the
Table 1. Baseline characteristics by diagnosis: all participants
Diagnosis (n) Control (39) AD (38) VAD (32) DLB (30) PDD (40)
Mean Age (SD)* 75 (6.4) 79 (5.8) 79 (6.2) 76 (7.1) 72 (6.0)
Gender: male (%) 21 (53.8) 18 (47.4) 23 (71.9) 18 (60.0) 26 (65.0)
Median duration of dementia: months (IQR) - 36 (21–48) 18 (9–30) 24 (12–48) 24 (15–48)
Mean CAMCOG score (SD)** 94 (4.7) 59 (15) 64 (18) 59 (15) 64 (16)
Resident in care home n (%) 0 (0) 6 (15.8) 6 (18.8) 9 (30) 3 (7.5)
History of falls in previous 12 months n (%) *** 13 (33.3) 19 (51.4) 21 (65.6) 18 (69.2) 33 (86.8)
History of recurrent falls in previous 12 months n (%) { 2 (5.1) 10 (26.3) 17 (53.1) 12 (40.0) 29 (72.5)
Uses walking aid or requires assistance to walk n (%) {{ 3 (7.7) 5 (13.2) 9 (28.1) 14 (46.7) 27 (67.5)
Cardiovascular medication n (%) {{{ 19 (48.7) 27 (71.1) 28 (87.5) 20 (66.7) 39 (97.5)
Psychotropic medication n (%) { 5 (12.8) 11 (28.9) 19 (59.4) 15 (50.0) 20 (50.0)
Symptomatic orthostatic hypotension n (%) {{ 0/39 (0) 2/37 (5.4) 3/31 (9.7) 4/26 (15.4) 12/38 (31.6)
SD: Standard deviation; IQR: Inter-quartile range; AD: Alzheimer’s disease; VAD: Vascular dementia; DLB: Dementia with Lewy bodies; PDD: Parkinson’s disease dementia;
PD: Parkinson’s disease. Denominators are given for prevalence (%) where data is incomplete.
*Control vs. patients p = 0.457; Control vs. AD p= 0.036; control vs. VAD p=0.027; Control vs. DLB p= 0.945; Control vs. PDD p= 0.031.
**Control vs. all patient groups p,0.001. No significant differences between patient groups.
***Control vs. AD p= 0.087; control vs. VAD p= 0.009; Control vs. DLB p= 0.005; Control vs. PDD p,0.001
{Control vs. AD p= 0.013; control vs. VAD p,0.001; Control vs. DLB p= 0.001; Control vs. PDD p,0.001
{{Control vs. AD p= 0.481; control vs. VAD p,0.024; Control vs. DLB p,0.001; Control vs. PDD p,0.001
{{{Control vs. AD p= 0.063; control vs. VAD p= 0.001; Control vs. DLB p= 0.151; Control vs. PDD p,0.001
{Control vs. AD p= 0.098; control vs. VAD p,0.001; Control vs. DLB p= 0.001; Control vs. PDD p= 0.001
{{Control vs. AD p= 0.234; control vs. VAD p,0.082; Control vs. DLB p,0.022; Control vs. PDD p,0.001
doi:10.1371/journal.pone.0005521.t001
Figure 2. Survival curve showing time to first fall by diagnosis.
doi:10.1371/journal.pone.0005521.g002
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preceding 12 months, use of cardioactive medication, autonomic
symptom scale greater than 7 and time taken for blood pressure to
return to baseline on standing remained significant predictors of
falls. Increased physical activity remained protective.
Multivariate predictors of falls and recurrent falls in
dementia
Significant potentially modifiable predictors were entered into
multivariate analyses in the order: age, gender, Tinetti gait score,
Cornell depression score, physical activity score, autonomic
symptom score, symptomatic orthostatic hypotension, use of
cardioactive medication and time for systolic blood pressure to
return to baseline on standing.
In the first model including all participants with dementia,
predictors retained were Cornell depression score, total autonomic
symptom score and symptomatic orthostatic hypotension. In the
second model, stratified by diagnosis, predictors retained were
symptomatic orthostatic hypotension, use of cardioactive medica-
tion and physical activity score, which was protective (Table 4).
Discussion
In the largest prospective study of predictors of falls in dementia
to date, we have demonstrated that older people with dementia
experience 8 times more incident falls than those without
dementia. These figures are even more striking when only
community dwelling people with dementia are considered, with
incidence in people with dementia nearly 10 times higher than in
those without dementia. Patients with Lewy Body dementias (DLB
or PDD) were at the highest risk, with DLB patients sustaining 6
times the number of falls in the control group and PDD 20 times
Table 2. Annual incidence of falls
Control (39) AD (38) VAD (32) DLB (30) PDD (40)
Incidence: number of falls/1000 person years 1023 2486 3135 9087 19 000
Incidence density ratio (95% CI) c.f. control group 1 1.95 (1.01–3.78) 1.77 (1.17–2.69) 6.06 (3.53–10.4) 20.5 (10.4–40.2)
Incidence density ratio (95% CI) c.f. AD group 1 0.907 (0.504–1.63) 3.10 (1.16–8.28) 10.5 (3.32–33.1)
Incidence density ratio (95% CI) c.f. VAD group 1 3.41 (1.96–5.95) 11.6 (5.73–23.3
Incidence density ratio (95% CI) c.f. DLB group 1 3.38 (2.66–4.31)
Fractures: number of fractures recorded during study 0 1 1 2 3
doi:10.1371/journal.pone.0005521.t002
Table 3. Univariate predictors of falls in participants with dementia
Diagnosis n All participants with dementia Stratified by diagnosis
Relative
Hazard ratio
95% confidence
intervals
Relative
Hazard ratio
95% confidence
intervals
Non modifiable risk factors
Age (years) 140 0.969 0.940–0.999 0.999 0.968–1.03
Male Gender 140 1.08 0.710–1.65 1.04 0.679–1.60
Diagnosis of Lewy Body disorder (PDD or DLB) 140 3.33 2.11–5.26 - -
Duration of dementia (per month) 133 1.01 0.998–1.02 1.02 1.00–1.02
Resident in care home 140 1.57 0.814–3.02 1.76 0.878–3.55
History of falls in previous 12 months 140 2.52 1.52–4.17 2.04 1.21–3.46
History of recurrent falls in previous 12 months 140 2.79 1.82–4.29 2.28 1.44–3.63
CAMCOG score (0–105, per point) 131 0.999 0.984–1.01 1 0.984–1.02
Potentially modifiable risk factors
Cardioactive medication 140 2.08 1.15–3.75 1.91 1.03–3.54
Psychotropic medication 140 1.49 0.986–2.25 1.36 0.885–2.07
Tinetti gait score ,7 and/or Tinetti balance score ,22 139 2.12 1.39–3.24 1.14 0.678–1.90
Physical activity score (0–9, per point) 140 0.818 0.723–0.926 0.873 0.766–0.994
NPI aberrant motor behaviour sub-score (0–12, per point) 121 0.989 0.922–1.06 0.982 0.916–1.05
Cornell score $10 132 2.01 1.18–3.43 1.26 0.728–2.18
Total autonomic symptom score $7 139 2.27 1.49–3.45 1.64 1.02–2.63
Definite, atypical or severe autonomic neuropathy 93 2.01 1.16–3.47 1.24 0.688–2.24
Symptomatic orthostatic hypotension 132 2.07 1.19–3.61 1.47 0.823–2.62
Time taken for blood pressure to return to baseline on
standing (per second)
133 1 1.00–1.01 1 1.00–1.01
doi:10.1371/journal.pone.0005521.t003
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more falls. The annual incidence of falls was higher in the LB
dementias than in all other groups studied and much higher than
any previous reports in older people[33]. Incidence of falls was
higher in PDD than in DLB.
To our knowledge, this is the first study which has identified
predictors specific to dementia, including the identification of non-
modifiable predictors such as a diagnosis of Lewy body disorder,
longer duration of dementia and previous history of falls or
recurrent falls. These factors will be useful in identifying
individuals at particular risk, who may benefit from further
assessment and intervention. Even more importantly, a number of
the predictors identified are potentially modifiable, and should be
included as key elements of a multifactorial intervention. These
factors included use of cardioactive medications, autonomic
symptoms, symptomatic orthostatic hypotension, depression and
limitation of physical activity. We suggest that interventions
targeted towards these predictors could reduce the burden of falls
related morbidity and mortality in community dwelling people
with mild-moderate dementia.
Our study has a number of strengths which reinforce our
findings. This was a prospective study and the majority of
participants had mild-moderate dementia and were residing in the
community. The incidence of falls was determined by completion
of daily diaries, with the support of a caregiver where appropriate,
with an adequate follow up period. The use of this method is
particularly important because it has the highest sensitivity for
accurate recording of falls. The number of participants in our
study was high (179); 80% of those approached agreed to take part
and compliance with fall diary returns was also high. Statistical
analysis was strengthened by the use of Cox regression models and
loglinear analysis of incidence densities, thus taking account of
censoring of falls diaries in some participants. All analyses included
adjustment for age and gender and the inclusion of multivariate
analyses enabled efficient estimate of significant associations while
adjusting for a number of confounding factors simultaneously.
There are some potential limitations to this study. Ideally, we
would have recruited both groups using random sampling from a
community population. Unfortunately the scale of such an exercise
would have been well beyond the resources available for this study.
Healthy older people volunteering for participation in research in
response to advertisements are often fitter than the older
population at large, but interestingly the incidence of falls in our
control group was very similar to that found in most community
based studies, suggesting that the control group was reasonably
representative, despite the limitations of using this recruitment
method. The recruitment of the patient participants from
secondary care clinics rather than from primary care may have
biased the sample towards those with more progressive disease.
However, in the northern region of the UK, suspected cases of
Parkinson’s disease are routinely referred to a secondary care
physician specialising in movement disorders (either a Neurologist
or Geriatrician). These patients should, therefore, be reasonably
representative of all patients presenting to primary care physicians
with symptoms suggestive of PD. There is a greater likelihood of
patients with AD or VAD not being referred to secondary care as
dementia is often undetected, or not managed by a specialist in
memory disorders. The reader should therefore bear in mind that
participants in this study may have had more severe or progressive
disease than those generally seen in primary care. In interpreting
our results, consideration should be given to the need to stratify for
dementia subtypes in univariate and multivariate analyses. Some
of the predictors were not significant when analyses were stratified
by dementia subtype, probably because these predictors were
actually surrogate markers of a diagnosis of a Lewy body disorder,
which itself predicted falls. In comparison with the proportions in
the general population the LB dementias were over represented in
our study, in order to make valid comparisons between dementia
subtypes.
Prior to commencement of our study we identified only two
studies of falls in dementia which included a fully multifactorial
assessment of risk factors, the first of which had an inadequate
follow up period,[34] and in the second the primary outcome was
fall related serious injuries rather than falls.[35] Both of those
studies included fewer than 100 participants, and neither included
a control group. Two studies published since we commenced our
study have included multifactorial baseline assessments, but the
first of these was small (only 42 participants with advanced
AD).[36] The second was a high quality study of 124 participants
in which neuroleptic drug use and grade 2 white matter lesions
predicted falls in multivariate analyses, but only participants with
AD were included, and there was no control group[37]. The
design of our study addressed these issues; to our knowledge, it is
the first to examine falls in both AD and non-AD dementias over
an adequate follow up period.
Exclusive to our study was the phasic measurement of blood
pressure using beat-to-beat recordings, thus enabling detection of
both magnitude and timing of blood pressure changes. Symptom-
atic OH and the length of time blood pressure fell below baseline
rather than the magnitude of the drop were predictive of falls. Our
group has previously shown an association between intermittent
hypotension and white matter lesions,[38] and this resonates with
the findings of Horikawa et al. that grade 2 white matter lesions
predicted falls in multivariate analyses[37]. White matter lesions
can be associated with abnormal gait,[39] and it is possible that
Table 4. Multivariate predictors of falls in participants with dementia
Diagnosis All participants with dementia Stratified by diagnosis
Relative Hazard
ratio
95% confidence
intervals
Relative Hazard
ratio
95% confidence
intervals
Predictors of falls
Cornell depression score (0–40, per point) 1.05 1.01–1.10
Total Autonomic symptom score (0–36, per point) 1.05 1.01–1.10
Symptomatic orthostatic hypotension 2.13 1.19–3.80 2.2 1.19–4.06
Physical activity score (0–9, per point) 0.827 0.716–0.956
Use of cardioactive medication 1.98 0.994–3.96
doi:10.1371/journal.pone.0005521.t004
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intermittent symptomatic hypotension against a background of
gait and balance instability exacerbates the likelihood that an older
person will fall. A higher level of physical activity was a protective
factor in our study. The physical activity scale measured all
physical activity rather than wandering, which has been shown in
one study to be a predictor of falls in dementia.[40] It is likely that
the more active patients were those with fewer problems with
mobility, whereas the participants with disturbed mobility
restricted their activity because of fear of falling, thus having
fewer opportunities to fall.
We believe that randomised multifactorial intervention trials to
prevent falls in mild-moderate dementia should now be made a
priority. Possible management strategies could include manage-
ment of the potentially modifiable factors identified in this study;
for example, the use of selective serotonin reuptake inhibitors for
depression, manipulation of cardiovascular medications, adequate
hydration and targeted drug therapies such as fludrocortisone and
midodrine for OH. Such a focus would differ from multifactorial
interventions in older people without dementia, which prioritise
strength and balance exercises that are more difficult for those
with impairment of recall to continue following initial intervention.
It is possible that encouragement of overall physical activity may
be successful in prevention of falls in dementia. However, such an
approach may increase opportunities for falling in individuals at
risk; similarly, aggressive treatment of motor features in LB
dementias might increase activity related opportunities to fall, and
also exacerbate OH. There is also a possibility that changes in
psychotropic medication might result in side effects such as
hypotension or somnolence, which could paradoxically increase
the risk of falls. This emphasises the importance of the conduction
of randomised controlled trials to ensure that modification of the
risk factors identified is the correct strategy.
We conclude that whilst the outcome of future trials are awaited
best clinical practice should focus on identification and manage-
ment of orthostatic hypotension, depression and maintenance of
physical activity in individuals who do not have severely impaired
gait and balance, whilst bearing in mind the need to monitor
patients carefully because of the potential side effects of these
changes.
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